Lergypax 40 orodispersible tablets

7,59€

0,19€/unité

Amount

Do not exceed the recommended daily dose, keep out of reach of children.

Information relating to the precautions for use (drug interactions, contraindications, special warnings, adverse effects, etc.) as well as the dosage are detailed in the medicine's leaflet.

Report an adverse effect

Lergypax orodispersible tablets is a medicine used in the adjunctive treatment of certain allergic manifestations such as spasmodic rhinitis, allergic conjunctivitis and hay fever.

C.I.P. reference : 3400921898002

Warning Medicine

40 unités

Minimum age : 30 mois

Nature de produit : Sublingual tablets
Conditionnement : Blister pack
Indication / Contre-indication : Dermatologically tested

Instructions for use

Instructions for use [PDF]

Summary of Product Characteristics [PDF]

Public drug database - SPC link

PDF user manual

‹ Return Ask a question ›

Photo non contractuelle - All prices include VAT - excluding delivery costs. Page updated on 17/02/2025